Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Exclusion Criteria

• •1. Age \< 18 years
• •2. Any Malignant patient
• •3. Patients with bacterial or viral or fungal pneumonia based on the judgment of the attending physician
• •4. Patients who had a history of any pulmonary cystic lesion such as infected bulla, bullous emphysema
• •5. Patients who were diagnosed with pulmonary fungal infection or previous its history or any documented culture of the fungus from a bronchial sample including sputum
• •6. Patients who were diagnosed with bronchiectasis
• •7. Patients who were diagnosed with NTM-PD (non-tuberculous mycobacterial pulmonary disease) or any documented culture of NTM from a bronchial sample including sputum
• •8. Patients who were diagnosed with connective tissue disease such as Wegener's granulomatosis, SLE
• •9. Patients who were diagnosed with TB destroyed lung
• •10. Patients who were diagnosed with congenital lung disease such as Congenital Cystic Adenomatoid Malformation (CCAM), pulmonary sequestration
• •11. Patients who were diagnosed with interstitial lung disease such as Lymphangioleiomyomatosis (LAM), idiopathic pulmonary fibrosis (IPF)
• •12. Patients who were diagnosed with culture-negative pulmonary TB
• •13. Patients who did not take anti-TB medication more than twice a week on average
• •14. Patients who were diagnosed with sarcoidosis
• •15. Patients who were diagnosed with paragonimiasis
• •16. Patients who were diagnosed with pulmonary thromboembolism due to excluding pulmonary infarction
• •17. The patient who did not consent
• •18. Patients who were diagnosed with MDR/XDR TB through AFB culture
• •B. Endobronchial TB Group
• •1. Age \< 18 years
• •2. Patient who was not consented